Expandable platform
A cobalt-chromium stent architecture designed for controlled balloon expansion.
PHTPolymeric Heart TechnologyHeart valve innovation · Florida, USA
Engineering a new path for polymeric heart valves.
Polymeric Heart Technology is developing the Expandable Polyurethane Trivalve Stent, a pediatric heart valve prosthesis that unites polymer science, precision engineering, and transcatheter delivery.
Florida LLCUnited States platform
Polymer + Co–CrIntegrated valve architecture
TranscatheterBalloon-expandable concept
FROM SCIENCE TO CLINICAL POSSIBILITY
A platform created to rethink durability, adaptability, and long-term care.
01 / TECHNOLOGY
One integrated valve platform
The Expandable Polyurethane Trivalve Stent integrates three flexible polyurethane leaflets with an expandable cobalt–chromium stent in a compact, balloon-expandable system.
Polymeric leaflets
Three medical-grade thermoplastic polyurethane leaflets engineered for flexibility and repeated cardiac cycles.
Transcatheter delivery
A valve platform under development for pulmonary and future aortic applications.
Platform architecture
Built around three essential components.
A controlled interface between structure, leaflets, and delivery is central to the development program.
01
Cobalt–chromium stentLaser-cut expandable structure
02
Medical-grade TPUThin, flexible polymeric leaflets
03
Balloon catheterControlled delivery and expansion
THE VALVE IN MOTION
Three leaflets. One coordinated cycle.
SCHEMATIC · END-ON VIEWClosing / leaflet coaptation
Right ventriclePulmonary artery
Expandable Polyurethane Trivalve Stent
The stent supports the leaflets. Balloon expansion is a separate procedure; the stent does not expand with each heartbeat.
Illustrative mechanism only. Geometry, leaflet motion, flow, and cycle timing are schematic and do not represent measured device performance. Investigational technology.
02 / PEDIATRIC FOCUS
Expandable Polyurethane Trivalve Stent
PHT’s pediatric polymeric heart valve prosthesis combines three polyurethane leaflets with an expandable stent. Developed for pulmonary valve replacement, the concept is designed with growing hearts in mind.
PEDIATRIC GROWTH
InitialExpandedFuture
One platform. Multiple diameters.
A balloon-expandable architecture conceived for controlled enlargement over time.
Pulmonary application
Focused on transcatheter pulmonary valve replacement for pediatric and congenital heart disease pathways.
Growth-aware architecture
The expandable cobalt–chromium frame is being engineered to accommodate planned increases in diameter as the patient grows.
Long-term objective
The development goal is to reduce the burden of repeated valve replacement procedures while preserving future treatment options.
Investigational concept. Safety, performance, expandability, and clinical benefit must be established through preclinical and clinical evaluation and regulatory review.
03 / DEVELOPMENT
Evidence-led development
PHT is organizing the next phase of industrial, quality, regulatory, and clinical work around a controlled development pathway.
Preclinical foundation
Historical development includes bench testing, fatigue evaluation, preclinical implantation, and explant analysis. All external claims remain subject to documented regulatory and scientific review.
- Bench hydrodynamic evaluation
- Accelerated fatigue testing
- Preclinical ovine studies
- Material and structural analysis
DEVELOPMENT PATHWAY
01
Design & materials
Valve geometry, stent architecture, and polymer selection
02
Process development
Coating and molding process evaluation
03
Verification
Hydrodynamic, fatigue, and structural testing
04
Clinical pathway
Regulatory engagement and study planning
04 / COMPANY
Science, enterprise, and execution
SHT and PHT contribute distinct capabilities while preserving clear institutional roles in Brazil and the United States.
SHT
Scientific origin, historical research, and foundational technology in Brazil.
PHT LLC
U.S. enterprise for development, industrialization, and future production.
1977Cardiac prosthesis research begins
2013Synthetic Heart Technology founded in Brazil
2026Polymeric Heart Technology established in Florida
NextIndustrial and clinical development in the United States
05 / LEADERSHIP
Multidisciplinary by design
Clinical experience, engineering, industrial development, and business execution come together around one mission.
01Miguel Angel Maluf, MD, PhD
Founder · Clinical & Scientific Leadership
02Marcelo Dias
Engineering & Industrial Development
03Marcio Velten
Business Development
Build the future with us
Advancing polymeric valve technology through collaboration.
Polymeric Heart Technology LLC
1905 Intermodal Circle, Suite 320
Palmetto, Florida 34221 · USA